These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4745860)

  • 1. Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes.
    Röllinghoff M; Wagner H
    J Natl Cancer Inst; 1973 Oct; 51(4):1317-8. PubMed ID: 4745860
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity in vitro against syngeneic mouse plasma tumour cells.
    Wagner H; Röllinghoff M
    Nat New Biol; 1973 Jan; 241(106):53-4. PubMed ID: 4540590
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary and secondary immune response induced in vitro against syngeneic murine plasma cell tumors.
    Röllinghoff M; Wagner H
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:304. PubMed ID: 4546887
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the physiological manifestations of cell-mediated cytotoxicity. I. Early metabilic changes in mouse plasmacytoma cells exposed in vitro to sensitized allogeneic splenocytes.
    Steinitz M; Weiss DW
    Cell Immunol; 1975 Feb; 15(2):403-18. PubMed ID: 122916
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro induction and expression of T-cell immunity to tumor-associated antigens.
    Burton RC; Chism SE; Warner NL
    Contemp Top Immunobiol; 1978; 8():69-106. PubMed ID: 357081
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the physiological manifestations of cell mediated cytotoxicity. II. Inhibition of (3-H)thymidine incorporation by plasmacytoma cells exposed in vitro to sensitized splenocytes.
    Steinitz M; Feigis M; Weiss DW
    Cell Immunol; 1975 May; 17(1):181-91. PubMed ID: 1125987
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
    Burton RC; Warner NL
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
    Röllinghoff M; Wagner H
    Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated cytotoxic reactions to tumor associated antigens.
    Herberman RB
    J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated cytotoxicity toward human lymphocytes: comparison between in vivo immunization and in vitro sensitization.
    Mawas C; Christen Y; Legrand L; Dausset J
    Transplant Proc; 1973 Dec; 5(4):1691-5. PubMed ID: 4130078
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
    Ben-Efraim S; Ophir R; Relyveld EH
    Br J Cancer; 1981 Apr; 43(4):554-7. PubMed ID: 6786316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.